WuXi AppTec Portfolio

Maxxam, in partnership with Ensemble Investments, acquired this 367,626 SF portfolio of three fully-leased, purpose-built life sciences buildings in the Navy Yard submarket of Philadelphia. All three properties are 100% net-leased to WuXi AppTec, Inc., a global biopharmaceutical and medical device company, and serves as the primary U.S. life sciences hub and North American headquarters of WuXi. These state-of-the-art research, development and manufacturing facilities were developed between 2004 and 2020, and house WuXi’s cell therapy, medical device and biologics testing and genomics research, along with ancillary office and storage areas.